Management of traumatic brain injury in the acute and recovery periods

Traumatic brain injury (TBI) is one of the leading causes of mortality and disability in patients. According to WHO, about 1.4 million traumatic brain injuries are registered annually. Among the survivors of this type of pathology, only 10% can return to their previous work and only 2% are satisfied with the quality of life. Therefore, the improvement of diagnostics and the search for effective treatments for TBI are among the most important tasks of modern science and practice.

The topic of providing care to patients with TBI in the acute and recovery periods was discussed at the 10th anniversary conference “Carpathian Readings”, which took place on June 9-11 in Uzhgorod.

The President of the Association of Neurosurgeons of Ukraine, Doctor of Medical Sciences, Professor V.I. Smolanka (Uzhgorod National University).

Prepared by Tetiana Chystyk

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design